These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11361868)

  • 1. First clinical data presented on FortovAse.
    AIDS Patient Care STDS; 1997 Dec; 11(6):455. PubMed ID: 11361868
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety and efficacy of ritonavir and saquinavir in combination with zidovudine and lamivudine.
    Michelet C; Bellissant E; Ruffault A; Arvieux C; Delfraissy JF; Raffi F; Bazin C; Renard I; Sébille V; Chauvin JP; Dohin E; Cartier F
    Clin Pharmacol Ther; 1999 Jun; 65(6):661-71. PubMed ID: 10391672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double protease inhibitor regimens with amprenavir show promise.
    AIDS Patient Care STDS; 1998 Apr; 12(4):317-8. PubMed ID: 11361962
    [No Abstract]   [Full Text] [Related]  

  • 4. Data in from first head-to-head protease inhibitor.
    AIDS Patient Care STDS; 1998 Apr; 12(4):317. PubMed ID: 11361961
    [No Abstract]   [Full Text] [Related]  

  • 5. HIV-associated pityriasis rubra pilaris responsive to triple antiretroviral therapy.
    González-López A; Velasco E; Pozo T; Del Villar A
    Br J Dermatol; 1999 May; 140(5):931-4. PubMed ID: 10354036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stavudine, lamivudine and indinavir in children with advanced HIV-1 infection: preliminary experience.
    Monpoux F; Sirvent N; Cottalorda J; Mariani R; Lefbvre JC
    AIDS; 1997 Oct; 11(12):1523-5. PubMed ID: 9342078
    [No Abstract]   [Full Text] [Related]  

  • 7. Saquinavir interaction with midazolam: pharmacokinetic considerations when prescribing protease inhibitors for patients with HIV disease.
    Merry C; Mulcahy F; Barry M; Gibbons S; Back D
    AIDS; 1997 Feb; 11(2):268-9. PubMed ID: 9030388
    [No Abstract]   [Full Text] [Related]  

  • 8. Prospective follow-up of 67 indinavir-experienced human immunodeficiency virus-infected and AIDS patients treated with the ritonavir/saquinavir combination.
    Lallemand F; Adda N; Schneider V; Jacomet C; Salhi Y; Rozenbaum W
    Clin Infect Dis; 1999 May; 28(5):1184-5. PubMed ID: 10452672
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment options for human immunodeficiency virus.
    Heins JR
    S D J Med; 1996 Feb; 49(2):51-2. PubMed ID: 9122670
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical application of HIV protease inhibitors].
    Chiba N; Shintani M; Ueno T; Hayashi H
    Tanpakushitsu Kakusan Koso; 1998 May; 43(6):744-51. PubMed ID: 9612068
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiretroviral triple therapy decreases HIV viral load but does not alter hepatitis C virus (HCV) serum levels in HIV-HCV-co-infected haemophiliacs.
    Rockstroh JK; Theisen A; Kaiser R; Sauerbruch T; Spengler U
    AIDS; 1998 May; 12(7):829-30. PubMed ID: 9619824
    [No Abstract]   [Full Text] [Related]  

  • 12. Abacavir (1592) with protease inhibitors in potent antiretroviral activity.
    AIDS Patient Care STDS; 1998 Apr; 12(4):315-6. PubMed ID: 11361959
    [No Abstract]   [Full Text] [Related]  

  • 13. Regression of cytomegalovirus retinitis associated with protease-inhibitor treatment in patients with AIDS.
    Tanguilig GG; Rutzen AR; Ortega-Larrocea G
    Am J Ophthalmol; 1998 Apr; 125(4):567-8. PubMed ID: 9559752
    [No Abstract]   [Full Text] [Related]  

  • 14. Complete regression of giant molluscum contagiosum lesions in an HIV-infected patient following combined antiretroviral therapy with saquinavir, zidovudine and lamivudine.
    Hurni MA; Böhlen L; Furrer H; Braathen LR
    AIDS; 1997 Nov; 11(14):1784-5. PubMed ID: 9386818
    [No Abstract]   [Full Text] [Related]  

  • 15. Challenges of antiretroviral treatment in transient and drug-using populations: the SUN study.
    Sension MG; Farthing C; Shaffer AG; Graham E; Siemon-Hryczyk P; Pilson RS
    AIDS Patient Care STDS; 2001 Mar; 15(3):129-36. PubMed ID: 11313025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The insufficient suppression of viral load by saquinavir hard gel is reversible: a retrospective cohort study.
    Jensen-Fangel S; Kirk O; Blaxhult A; Gerstoft J; Pedersen C; Black FT; Lundgren JD; Obel N
    HIV Clin Trials; 2001; 2(2):122-7. PubMed ID: 11590520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antiretroviral treatment in human immunodeficiency virus infection].
    Blum L; Bachmeyer C
    Ann Dermatol Venereol; 1997; 124(9):641-54. PubMed ID: 9739932
    [No Abstract]   [Full Text] [Related]  

  • 18. Randomized, controlled phase II trial of subcutaneous interleukin-2 in combination with highly active antiretroviral therapy (HAART) in HIV patients.
    Hengge UR; Goos M; Esser S; Exner V; Dötterer H; Wiehler H; Borchard C; Müller K; Beckmann A; Eppner MT; Berger A; Fiedler M
    AIDS; 1998 Dec; 12(17):F225-34. PubMed ID: 9863864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug shows potency against HIV.
    Dent Today; 1996 May; 15(5):22, 26. PubMed ID: 9567867
    [No Abstract]   [Full Text] [Related]  

  • 20. Potent new AIDS drugs underscore promise of combination therapy.
    AIDS Alert; 1996 Jan; 11(1):1-4. PubMed ID: 11363225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.